3. Results
To investigate the demographic and health profile of the study participants, we analyzed key variables including age, weight, height, body mass index (BMI), heart rate, blood pressure, and biochemical markers such as hemoglobin, hematocrit, mean corpuscular volume (MCV), mean corpuscular hemoglobin concentration (MCHC), and C-reactive protein (CRP). These data, summarized in
Table 1, provide insights into the overall health and physical condition of the athletes.Given the gender composition of sports academies in Tacna, where the majority of athletes are male, this study focused exclusively on male adolescents. While females are more likely to have anemia during adolescence, this decision was based on the gender distribution within the sports academies. However, we acknowledge that the exclusion of female adolescents represents a limitation of the study, and future studies should aim to include both male and female adolescents to better understand the impact of parasitic infections and anemia across genders. As all participants were male, the gender ratio is not provided in the table.
In
Table 1, the demographic and general health data of the participants are presented, including age, weight, height, body mass index (BMI), heart rate, blood pressure, hemoglobin, hematocrit, mean corpuscular volume (MCV), mean corpuscular hemoglobin concentration (MCHC), and C-reactive protein (CRP). The mean hemoglobin level was 12.8 g/dL, with a range of 11.2 - 13.8 g/dL, and the prevalence of anemia in this group was 20%. The participants had a mean CRP of 4.2 mg/L, suggesting moderate inflammation in the studied population.
To assess the effects of parasitic infections on hematological and biochemical parameters, we compared key markers such as hemoglobin, hematocrit, mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and C-reactive protein (CRP) between infected and non-infected athletes. Significant differences were observed in these markers
(Table 2).
In
Table 2, hematological and biochemical parameters for infected and non-infected athletes are provided. Infected athletes had a mean hemoglobin of 11.9 g/dL and hematocrit of 35.5%, whereas non-infected athletes had a mean hemoglobin of 13.8 g/dL and hematocrit of 40.2%. Mean corpuscular volume (MCV) for infected athletes was 80.0 fL, and for non-infected athletes, it was 85.5 fL. Similarly, mean corpuscular hemoglobin (MCH) and mean corpuscular hemoglobin concentration (MCHC) were lower in the infected group. C-reactive protein (CRP) was significantly higher in infected athletes, with a mean of 5.0 mg/L compared to 2.2 mg/L in non-infected athletes.
Infected athletes showed significant differences in MCV and MCH compared to non-infected athletes
(Table 4).
To investigate the relationship between inflammation and anemia, we analyzed the association between C-reactive protein (CRP) levels, hemoglobin concentrations, and the prevalence of anemia among athletes. To test the hypothesis that higher CRP levels are linked to increased anemia prevalence, a two-sample was conducted with a significance level set at p < 0.05. The p-value was calculated using a one-way ANOVA, followed by Welch’s test when the assumption of homogeneity of variance was not met, as confirmed by Levene’s test.
Anemia prevalence in the moderate CRP group was 18%, while in the high CRP group it reached 28%. The cutoff values for categorizing CRP levels as moderate and high were determined based on prior research. Moderate CRP levels were defined as those between 1 mg/L and 10 mg/L, while high CRP levels were defined as those exceeding 10 mg/L. These values were selected based on established guidelines in the literature, including Gabay & Kushner (1999) and Pepys & Hirschfield (2003), and are presented in
Table 3
Table 3.
Relationship between C-Reactive Protein (PCR) Levels and Hemoglobin Concentration in Athletes.
Table 3.
Relationship between C-Reactive Protein (PCR) Levels and Hemoglobin Concentration in Athletes.
| PCR Levels (mg/L) |
N (%) |
Hemoglobin (g/dL, Mean ± SD) |
Anemia Prevalence (%) |
p-value |
| Low (<3 mg/L) |
112 (45%) |
13.4 ± 0.8 |
8% |
< 0.001 |
| Moderate (3-5 mg/L) |
88 (35%) |
12.6 ± 0.9 |
18% |
< 0.001 |
| High (>5 mg/L) |
45 (18%) |
11.8 ± 0.7 |
28% |
< 0.001 |
In
Table 3, the relationship between C-reactive protein (CRP) levels and hemoglobin concentration in athletes is shown. Athletes with low CRP levels (<3 mg/L) had the highest mean hemoglobin level of 13.4 g/dL and the lowest anemia prevalence at 8%. Athletes with moderate CRP levels (3-5 mg/L) had a mean hemoglobin of 12.6 g/dL and an anemia prevalence of 18%. The athletes with high CRP levels (>5 mg/L) had the lowest mean hemoglobin level of 11.8 g/dL and the highest anemia prevalence of 28%. The differences in hemoglobin levels and anemia prevalence between the three groups were statistically significant (p < 0.001), indicating a relationship between higher CRP levels and lower hemoglobin concentrations.
Table 4.
Relationship between Hemoglobin Levels and Additional Hematological and Biochemical Markers in Athletes.
Table 4.
Relationship between Hemoglobin Levels and Additional Hematological and Biochemical Markers in Athletes.
| Hemoglobin Levels (g/dL) |
N (%) |
Ferritin (ng/mL, Mean ± SD) |
MCV (fL, Mean ± SD) |
Serum Iron (µg/dL, Mean ± SD) |
p-value |
| Low (<12 g/dL) |
52 (21%) |
18.5 ± 5.8 |
74.8 ± 4.5 |
46.2 ± 11.5 |
< 0.001 |
| Normal (12-14 g/dL) |
148 (60%) |
51.5 ± 10.2 |
84.2 ± 5.4 |
73.5 ± 12.8 |
< 0.001 |
| High (>14 g/dL) |
45 (19%) |
80.2 ± 13.7 |
90.8 ± 5.2 |
94.5 ± 14.2 |
< 0.001 |
In
Table 4, the relationship between hemoglobin levels and additional hematological and biochemical markers in athletes is presented. Athletes with low hemoglobin levels (<12 g/dL) had significantly lower ferritin (18.5 ng/mL), mean corpuscular volume (MCV) (74.8 fL), and serum iron (46.2 µg/dL) compared to athletes with normal or high hemoglobin levels. Those with normal hemoglobin levels (12-14 g/dL) had higher ferritin (51.5 ng/mL), MCV (84.2 fL), and serum iron (73.5 µg/dL). Athletes with high hemoglobin levels (>14 g/dL) showed the highest ferritin (80.2 ng/mL), MCV (90.8 fL), and serum iron (94.5 µg/dL). All differences in these parameters between the three hemoglobin groups were statistically significant (p < 0.001), indicating a clear association between hemoglobin levels and the other hematological and biochemical markers.
To assess the impact of parasitic infections on hematological parameters, we investigated the relationship between the prevalence of different parasitic infections and key markers such as hemoglobin levels, hematocrit, and the prevalence of anemia. Athletes with parasitic infections, particularly those with mixed infections, exhibited significantly lower hemoglobin and hematocrit levels, along with a higher prevalence of anemia
(Table 5).
For both
Table 4 and
Table 5, five subjects were excluded from the analysis due to the identification of outliers in inflammatory and hematological biomarkers. These outliers were detected using the interquartile range (IQR) method to minimize their potential influence on the statistical results and ensure the validity and robustness of the analysis.
In
Table 5, the relationship between parasitic infections and hemoglobin levels in athletes is presented. Athletes infected with Giardia lamblia exhibited the lowest mean hemoglobin level (11.5 g/dL) and the highest anemia prevalence (35%). Athletes infected with Ascaris lumbricoides had a mean hemoglobin of 12.0 g/dL, with an anemia prevalence of 28%. Athletes infected with Trichuris trichiura showed a mean hemoglobin level of 11.8 g/dL and an anemia prevalence of 30%. Those with mixed infections had a mean hemoglobin of 11.3 g/dL and the highest anemia prevalence (45%). Finally, athletes without parasitic infections had the highest mean hemoglobin (13.7 g/dL) and the lowest anemia prevalence (5%). All differences in hemoglobin levels, hematocrit, and anemia prevalence across infection groups were statistically significant (p < 0.001), indicating that parasitic infections are strongly associated with lower hemoglobin levels and higher rates of anemia in athletes.
Athletes infected with Ascaris and Giardia exhibited significantly lower hemoglobin levels and higher prevalence of anemia. While this study focused on these two species, it is important to note that other parasitic infections prevalent in the region, such as Necator and Ancylostoma, could have played a significant role in the prevalence of anemia, which will be addressed in future investigations.
To investigate the relationship between nutritional status and anemia, we examined the distribution of body mass index (BMI), weight, height, and hemoglobin levels in athletes. The analysis was conducted on an adjusted sample size (N) to ensure a more natural distribution (
Table 6).
Additionally, when analyzing parasitic infection patterns by academy, no significant clustering of infection types was observed in the laboratory test results (p > 0.05).
Table 6 summarizes the relationship between nutritional status and anemia prevalence, including key variables such as body mass index (BMI), weight, height, and hemoglobin levels, among athletes. The data are presented by different BMI categories and their corresponding anemia rates.
In
Table 6, the relationship between body mass index (BMI) categories and hemoglobin levels in athletes is presented. Athletes classified as underweight (<18.5 kg/m
2) had the lowest mean hemoglobin (11.8 g/dL) and the highest anemia prevalence (30%). Athletes with normal weight (18.5-24.9 kg/m
2) had a higher mean hemoglobin level (13.1 g/dL) and a lower anemia prevalence (12%). Athletes classified as overweight (>25 kg/m
2) exhibited a mean hemoglobin of 12.6 g/dL and an anemia prevalence of 18%. All comparisons across BMI categories were statistically significant (p < 0.001), indicating that BMI categories are strongly associated with hemoglobin levels and anemia prevalence in athletes.
The differences in anemia frequencies reported in
Table 6 and
Table 8 reflect the inclusion of different analysis subgroups.
Table 6 presents general prevalence data for anemia in the total study population, while
Table 8 shows stratified frequencies considering physical activity levels and inflammatory biomarkers.
To investigate the relationship between anemia and erythrocyte indices, we compared the mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and mean corpuscular hemoglobin concentration (MCHC) between anemic and non-anemic athletes.
In
Table 7, the erythrocyte indices in athletes with and without anemia are presented. The data shows that athletes with anemia have significantly lower mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and mean corpuscular hemoglobin concentration (MCHC) compared to non-anemic athletes. Specifically, anemic athletes had an MCV of 76.5 fL, MCH of 24.5 pg, and MCHC of 31.0 g/dL, while non-anemic athletes had an MCV of 85.0 fL, MCH of 28.0 pg, and MCHC of 34.0 g/dL. These differences are statistically significant (p < 0.001), indicating that anemia is associated with reduced erythrocyte indices, which are commonly used to diagnose and assess the severity of anemia.
To investigate the impact of nutritional status on hematological health, we analyzed the relationship between nutritional categories and key hematological biomarkers in athletes. Athletes labeled as underweight were defined based on a body mass index (BMI) of less than 18.5 kg/m2, in accordance with standard WHO guidelines (WHO, 2006). These athletes showed significantly lower ferritin and iron levels compared to those in other BMI categories.
In contrast, athletes with normal weight demonstrated optimal levels of ferritin and serum iron. Overweight athletes displayed intermediate values.
Table 8.
Relationship between Nutritional Status and Hematological Biomarkers in Athletes.
Table 8.
Relationship between Nutritional Status and Hematological Biomarkers in Athletes.
| Nutritional Status |
N (%) |
Ferritin (ng/mL, Mean ± SD) |
Serum Iron (µg/dL, Mean ± SD) |
Hemoglobin (g/dL, Mean ± SD) |
Anemia Prevalence (%) |
p-value |
| Underweight (<18.5) |
50 (20%) |
15.0 ± 5.0 |
40.0 ± 10.0 |
11.5 ± 0.7 |
36% |
< 0.001 |
| Normal weight (18.5-24.9) |
160 (65%) |
50.0 ± 9.0 |
75.0 ± 12.0 |
13.3 ± 0.8 |
10% |
< 0.001 |
| Overweight (>25) |
40 (15%) |
35.0 ± 8.0 |
65.0 ± 14.0 |
12.1 ± 0.9 |
20% |
< 0.001 |
In
Table 8, the relationship between nutritional status and hematological biomarkers in athletes is presented. The data shows that athletes classified as underweight (<18.5 kg/m
2) had significantly lower ferritin, serum iron, and hemoglobin levels compared to those in the normal weight and overweight categories. Specifically, underweight athletes had a mean ferritin level of 15.0 ng/mL, serum iron of 40.0 µg/dL, and hemoglobin of 11.5 g/dL, with a prevalence of anemia of 36%. In contrast, athletes with normal weight had a mean ferritin level of 50.0 ng/mL, serum iron of 75.0 µg/dL, and hemoglobin of 13.3 g/dL, with a significantly lower anemia prevalence of 10%. Athletes in the overweight category had intermediate values: a mean ferritin of 35.0 ng/mL, serum iron of 65.0 µg/dL, and hemoglobin of 12.1 g/dL, with a prevalence of anemia of 20%. All comparisons between groups showed statistically significant differences (p < 0.001), suggesting that nutritional status is an important factor in hematological health, with underweight athletes being more prone to anemia.
Nutritional status was classified as underweight (<-2 standard deviations), normal weight (≥-2 and ≤+1 standard deviations), and overweight (>+1 standard deviation), according to World Health Organization (WHO, 2006) guidelines.
To assess the relationship between age and anemia prevalence, we compared hemoglobin levels and anemia rates across two age groups: 13-15 years and 16-18 years. Additionally, the average hemoglobin levels in the 16-18 age group (12.8 g/dL) were slightly lower than those in the 13-15 age group (13.2 g/dL).
In
Table 9, the hemoglobin levels and anemia prevalence by age group are presented. The 13-15 year age group had a mean hemoglobin level of 13.2 ± 1.2 g/dL with a 12% prevalence of anemia. In contrast, the 16-18 year age group had a slightly lower mean hemoglobin level of 12.8 ± 1.3 g/dL and a higher prevalence of anemia at 18%. The 13-15 year age group showed a higher prevalence of parasitic infections (30%) compared to the 16-18 year group (20%). Additionally, the PCR levels were higher in the 16-18 year age group (6.2 mg/L) compared to the 13-15 year group (4.5 mg/L), indicating a potential correlation between age, infection rates, and inflammatory response.
The analysis of the prevalence of anemia in the younger (13-15 years) and older (16-18 years) age groups was enhanced by examining the percentage of parasitic infections and the mean CRP levels within these groups. As shown in
Table 9, the younger group (13-15 years) had a higher prevalence of parasitic infections (30%) and a mean CRP level of 4.5 mg/L, while the older group (16-18 years) showed a lower prevalence of parasitic infections (20%) but had higher mean CRP levels (6.2 mg/L). These findings emphasize the intricate relationship between age, inflammation, and parasitic infections, suggesting a cumulative effect that heightens the risk of anemia in older adolescents. This underscores the need for targeted interventions to prevent anemia progression, particularly in those exposed to chronic inflammation and parasitic infections.
To predict the presence of anemia (hemoglobin <12 g/dL), we performed a logistic regression analysis, comparing an unadjusted model with one adjusted for age and nutritional status. As shown in
Table 10, we compared the unadjusted and adjusted models.
In
Table 10, the logistic regression analysis results for predicting anemia based on CRP and BMI (IMC) are presented. The unadjusted odds ratio for CRP (1.25, 95% CI: 1.10-1.45) was significantly associated with an increased risk of anemia (p < 0.001), suggesting that higher CRP levels are linked to a higher likelihood of anemia. In contrast, the unadjusted odds ratio for BMI (0.95, 95% CI: 0.90-1.05) was not statistically significant (p = 0.075), indicating that BMI alone did not predict anemia in this model. When adjusted for other predictors (CRP, BMI, and age), the adjusted odds ratio for CRP (1.20, 95% CI: 1.08-1.38) remained significant (p < 0.001), supporting the finding that CRP is a strong predictor of anemia. However, the adjusted odds ratios for BMI (0.98, 95% CI: 0.91-1.06), age (1.02, 95% CI: 0.95-1.07), and nutritional status (1.10, 95% CI: 0.98-1.25) did not show significant associations with anemia (p = 0.250, p = 0.330, p = 0.085, respectively), indicating that these factors may not independently predict anemia in the presence of CRP.
Figure 01.
Correlation Heatmap of Hematological, Biochemical Markers, and Parasitic Infection in Adolescent Athletes.
Figure 01.
Correlation Heatmap of Hematological, Biochemical Markers, and Parasitic Infection in Adolescent Athletes.
To better understand the interconnections between inflammation, parasitic infections, and hematological health in adolescent athletes, we examined the correlations between various hematological and biochemical markers. The analysis revealed that hemoglobin and hematocrit levels were significantly negatively correlated with anemia (r = -0.80 and r = -0.78, respectively).
In contrast, C-reactive protein (PCR) showed positive correlations with both anemia 543 (r = 0.65) and parasitic infections (r = 0.58), suggesting that higher inflammation is associated with increased risk of anemia and parasitic infection in this population. Additionally, ferritin was positively correlated with hemoglobin (r = 0.50).
Ferritin levels were significantly lower in participants with anemia (mean: 15.8 ± 2.3 ng/mL) compared to those without anemia (mean: 31.5 ± 5.6 ng/mL, p < 0.01).
The inclusion of a non-athlete comparison group allowed us to better interpret the observed anemia in athletes. As shown in
Table 11, athletes exhibited a significantly higher prevalence of anemia (
30%) compared to non-athletes (
18%), and had a higher mean CRP level (
10.2 mg/L) and a greater prevalence of parasitic infections (
35%). These findings suggest that parasitic infections play a substantial role in the development of anemia in athletes, but also indicate that the increased physical activity may further exacerbate anemia through inflammatory mechanisms.
The study results show that anemia is more prevalent in athletes than in non-athletes, suggesting that factors related to physical activity, such as increased inflammation, contribute to its development. The comparison with non-athletes highlights the complex interaction between parasitic infections, inflammation, and iron deficiency. Athletes had higher CRP levels, which is related to chronic inflammation induced by parasitic infections, which in turn decreases hemoglobin levels. These findings are consistent with previous research suggesting that chronic inflammation increases the production of hepcidin, a negative regulator of iron, which contributes to anemia in vulnerable populations (Ganz, 2011; Crompton and Nesheim, 2002).
Table 12 provides a comparison between the demographic and infection characteristics of athletes and non-athletes. The results show that the average age of both groups is very similar, with athletes averaging 15.5 years and non-athletes averaging 15.2 years. Both groups are composed entirely of male participants (100%). The prevalence of Ascaris infection is higher in athletes (25%) compared to non-athletes (10%), while the prevalence of Giardia is also higher in athletes (12%) compared to non-athletes (6%). The prevalence of Trichuris is also slightly higher in athletes (6%) compared to non-athletes (3%). Additionally, the average hemoglobin level is lower in athletes (11.5 g/dL) compared to non-athletes (13.0 g/dL), indicating that athletes may have a higher prevalence of anemia. The percentage of underweight students is higher among athletes (12%) compared to non-athletes (8%), which may further indicate nutritional deficiencies within the athlete group.
Validity of the findings:
The relationship between parasitic infections and elevated CRP levels, reduced hemoglobin, and increased anemia risk was evaluated using adjusted statistical models that accounted for confounding variables such as age and nutritional status. These results align with previous research associating parasitic infections with inflammatory anemia, mediated by the activation of the innate immune response and the redistribution of iron to intracellular stores. Although no independent validation assay was performed, studies such as those by Stephenson et al. (2000) and Crompton & Nesheim (2002) support these findings. This suggests that parasitic infections are a significant factor in the development of anemia in vulnerable populations.